CD8A and neoplasm: Moreover, the previous report showed that the EGFR/AKT signal could promote tumor cell proliferation through regulating immune cells, such as CD8+ T cells recruited by CXC-chemokine ligand 10 (CXCL10) (Kumagai et al., 2021).